Quantifying Missing Heritability at Known GWAS Loci

Recent work has shown that much of the missing heritability of complex traits can be resolved by estimates of heritability explained by all genotyped SNPs. However, it is currently unknown how much heritability is missing due to poor tagging or additional causal variants at known GWAS loci. Here, we use variance components to quantify the heritability explained by all SNPs at known GWAS loci in nine diseases from WTCCC1 and WTCCC2. After accounting for expectation, we observed all SNPs at known GWAS loci to explain 1.29x more heritability than GWAS-associated SNPs on average (P=3.3 x 10(-5)). For some diseases, this increase was individually significant: 2.07x for Multiple Sclerosis (MS) (P = 6.5 x 10(-9)) and 1.48x for Crohn's Disease (CD) (P = 1.3 x 10(-3)); all analyses of autoimmune diseases excluded the well-studied MHC region. Additionally, we found that GWAS loci from other related traits also explained significant heritability. The union of all autoimmune disease loci explained 7.15x more MS heritability than known MS SNPs (P < 1.0 x 10(-16)) and 2.20x more CD heritability than known CD SNPs (P=6.1 x 10(-9)), with an analogous increase for all autoimmune diseases analyzed. We also observed significant increases in an analysis of >20,000 Rheumatoid Arthritis (RA) samples typed on ImmunoChip, with 2.37x more heritability from all SNPs at GWAS loci (P=2.3 x 10(-6)) and 5.33x more heritability from all autoimmune disease loci (P < 1 x 10(-16)) compared to known RA SNPs (including those identified in this cohort). Our methods adjust for LD between SNPs, which can bias standard estimates of heritability from SNPs even if all causal variants are typed. By comparing adjusted estimates, we hypothesize that the genome-wide distribution of causal variants is enriched for low-frequency alleles, but that causal variants at known GWAS loci are skewed towards common alleles. These findings have important ramifications for fine-mapping study design and our understanding of complex disease architecture.